Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Nov 16, 2025

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

Reply to S. Fuji

Andreas Burchert¹, Stephan K Metzelder¹, Andreas Neubauer¹

¹Andreas Burchert, MD, Stephan K. Metzelder, MD, and Andreas Neubauer, MD, Department of Internal Medicine, Hematology, Oncology and Immunology, Philipps University Marburg and University Hospital Giessen and Marburg, Campus Marburg, Marburg, Germany and Michael Wittenberg, PhD, and Carmen Schade-Brittinger, Coordinating Center for Clinical Trials, Philipps-University Marburg, Marburg, Germany.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

|February 23, 2021

Summary

No abstract available in PubMed .

More Related Videos

Large-scale Recording of Neurons by Movable Silicon Probes in Behaving Rodents

Large-scale Recording of Neurons by Movable Silicon Probes in Behaving Rodents

Published on: March 4, 2012

The Bionic Clicker Mark I & II

The Bionic Clicker Mark I & II

Published on: August 14, 2017

Related Experiment Videos

Last Updated: Nov 16, 2025

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

Large-scale Recording of Neurons by Movable Silicon Probes in Behaving Rodents

Large-scale Recording of Neurons by Movable Silicon Probes in Behaving Rodents

Published on: March 4, 2012

The Bionic Clicker Mark I & II

The Bionic Clicker Mark I & II

Published on: August 14, 2017

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Comprehensive molecular characterization of treatment-free remission and molecular relapse in chronic myeloid leukemia patients: the EURO-SKI Biomarker Study.

Leukemia·2026

Same author

Response to: Potential impact of NK-cell education on interferon efficacy in the ENDURE trial.

Leukemia·2026

Same author

Biostimulants from <i>Rosa alba</i> L. optimize growth and physiological processes of <i>Zea mays</i> L.

Frontiers in plant science·2026

Same author

Haploidentical transplantation with post-transplant cyclophosphamide is not inferior to 9/10-MUD transplantation with ATG in patients with myeloid malignancies.

Bone marrow transplantation·2026

Same author

Reassessing the adverse event profiles of levetiracetam and brivaracetam: a systematic review and meta-analysis.

Journal of neurology·2026

Same author

Metabolome Reprogramming During Fruit Ripening and Post-Harvest Storage in Ten Crop Species.

Metabolites·2026

Same journal

Biology Over Monotherapy: Mature Results From European Organisation For Research and Treatment of Cancer 22033-26033 Reaffirm Molecular Stratification, Not Treatment Sequence, Defines Prognosis in Low-Grade Glioma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Same journal

Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Same journal

Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Same journal

Efficacy and Tolerability of Zenocutuzumab in Advanced <i>NRG1</i> Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Same journal

Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Same journal

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

See all related articles